Efficacy and safety of Tripterygium glycosides as an add-on treatment in adults with chronic urticaria: a systematic review and meta-analysis

References

• Altman K, Chang C. 2013. Pathogenic intracellular and autoimmune mechanisms in urticaria and angioedema. Clin Rev Allergy Immunol. 45(1):47–62.
   PubMed Web of Science ®Google Scholar
• Altrichter S, Frischbutter S, Fok JS, Kolkhir P, Jiao Q, Skov PS, Metz M, Church MK, Maurer M. 2020. The role of eosinophils in chronic spontaneous urticaria. J Allergy Clin Immunol. 145(6):1510–1516.
   PubMed Web of Science ®Google Scholar
• Asero R, Tedeschi A, Coppola R, Griffini S, Paparella P, Riboldi P, Marzano AV, Fanoni D, Cugno M. 2007. Activation of the tissue factor pathway of blood coagulation in patients with chronic urticaria. J Allergy Clin Immunol. 119(3):705–710.
   PubMed Web of Science ®Google Scholar
• Chen T. 2017. Study on the effect of Tripterygium glycosides tablet combined with desloratadine in the treatment of chronic spontaneous urticaria. Chin Foreign Med Res. 15(7):24–26. Chinese.
   Google Scholar
• Chen XY. 2016. Assessment of the efficacy of ebastine combined with Tripterygium glycosides for chronic urticaria. For All Health. 10(6):145–145. Chinese.
   Google Scholar
• Chen M, Wang ML, Wang WW. 2017. Tripterygium glycosides tablet combined with desloratadine for 42 cases with chronic spontaneous urticaria. Chin J Ethnomed Ethnopharm. 26(20):87–88,95. Chinese.
   Google Scholar
• Chen Q, Zhong H, Chen WC, Zhai Z, Zhou Z, Song Z, Hao F. 2018. Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 32(3):441–448.
   PubMed Web of Science ®Google Scholar
• [CSD, CUR] Chinese Society of Dermatology, Centre for Urticaria Research. 2019. [Guideline for diagnosis and treatment of urticaria in China]. Chin J Dermatol. 51(1):1–5. Chinese.
   Google Scholar
• Dai Y, Sun L, Han S, Xu S, Wang L, Ding Y. 2022. Proteomic study on the reproductive toxicity of Tripterygium glycosides in rats. Front Pharmacol. 13:888968.
   PubMed Web of Science ®Google Scholar
• Dai S, Yin K, Yao X, Zhou L. 2013. Inhibition of interleukin-13 gene expression by triptolide in activated T lymphocytes. Respirology. 18(8):1249–1255.
   PubMed Web of Science ®Google Scholar
• Deng M, Liao YM, Liu JH. 2017. The evaluation of Tripterygium glycosides tablet combined with desloratadine for the treatment of chronic spontaneous urticaria. Forefront Med. 7(7):7–8. Chinese.
   Google Scholar
• Fricke J, Ávila G, Keller T, Weller K, Lau S, Maurer M, Zuberbier T, Keil T. 2020. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 75(2):423–432.
   PubMed Web of Science ®Google Scholar
• Gan MZ, Yu JJ, Deng Y. 2022. Clinical effect of Tripterygium glycosides combined with total glucosides of paeony for the treatment of Sjögren’s syndrome and their influences on anticardiolipin antibody and rheumatoid factor. Chin Arch Trad Chin Med. 40:94–96. Chinese.
   Google Scholar
• Gao P. 2020. Efficacy and safety of ebastine combined with Tripterygium glycosides tablet for the treatment of chronic urticaria. J Med Aesthet Cosmetol. 29(13):19–20. Chinese.
   Google Scholar
• Geng Q, Liu B, Ma Y, Li H, Shi N, Ouyang G, Nie Z, Yi J, Chen Y, Wang Y, et al. 2022. Effects and safety of the Tripterygium glycoside adjuvant methotrexate therapy in rheumatoid arthritis: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2022:1251478.
   PubMed Web of Science ®Google Scholar
• Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, Ben-Shoshan M, Bernstein JA, Ensina LF, Fomina D, Galvàn CA, Godse K, Grattan C, et al. 2021. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 184(2):226–236.
   PubMed Web of Science ®Google Scholar
• Guo HB, Peng JQ, Wang X, Zhang KK, Zhong GZ, Chen WH, Shi GX. 2021. Efficacy of Tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials. BMC Nephrol. 22(1):304.
   PubMed Web of Science ®Google Scholar
• He JX, Cai ZL, Huang WF. 2009. Observation of the effect of combination therapy on chronic spontaneous urticaria. Int Med Health Guid New. 15:76–77,83. Chinese.
   Google Scholar
• He L, Yi W, Huang X, Long H, Lu Q. 2021. Chronic urticaria: advances in understanding of the disease and clinical management. Clin Rev Allergy Immunol. 61(3):424–448.
   PubMed Web of Science ®Google Scholar
• He ZS. 2013. Study on the levels of total IgE, C3, C4, IL-2, IL-4, and IFN-γ in serum in the patients with chronic spontaneous urticaria [Dissertation]. Shijiazhuang, Hebei province, Hebei North University.
   Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, Cochrane Bias Methods Group 2011. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Br Med J. 343(oct18 2):d5928–d5928.
   PubMed Web of Science ®Google Scholar
• Li ZK, Wang CZ, Qian GS, Lin KX, Liu G. 2002. Effect of triptolide on expression of IL-5, IL-13 and GM-CSF receptors mRNA in BALF eosinophils of asthmatic guinea pigs. Immunol J. 18:102–106. Chinese.
   Google Scholar
• Lin KX, Wang CZ, Qian GS. 2000. Effect of triptolide on apoptosis of CD4+ and CD8+ T cells. Immunol J. 16(1):24–26. Chinese.
   Google Scholar
• Lin KX, Wang CZ, Qian GS. 2001. Effect of Tripterygium glycosides on the production of Th1 and Th2-related cytokines in asthma patients. Chin J Integr Med. 21(1):22–24. Chinese.
   Google Scholar
• Liu Z. 2016. Clinical effect of desloratadine combined with Tripterygium glycosides tablet on chronic spontaneous urticaria. Clin Med. 36(4):21–22. Chinese.
   Google Scholar
• Liu L, Zhao H, Sun X, Zheng Q, Luo Y, Ru Y, Zhang Y, Chen X, Zhu B, Yin C, et al. 2018. Efficacy and safety of Tripterygium wilfordii Hook F for chronic urticaria: a systematic review and meta-analysis. BMC Complement Altern Med. 18(1):243.
   PubMedGoogle Scholar
• Long T, Ding ZY, Wang W. 2021. Effect of desloratadine combined with Tripterygium glycosides tablet on the clinical efficacy and mood of patients with chronic spontaneous urticaria. J Int Psychiat. 48:1106–1109. Chinese.
   Google Scholar
• Lu T, Rao YT, Zhang J, Wang YY, Zhang W. 2021. Effect and mechanism of Tripterygium glycosides tablet for the treatment of rheumatoid arthritis. J Chin Med Mat. 44:2214–2218. Chinese.
   Google Scholar
• Luo Y, Zhang Y, Kuai L, Xing M, Ru Y, Luo Y, Liu L, Chen J, Li B, Li X. 2021. Efficacy and safety of Tripterygium glycosides in Sjögren’s syndrome treatment: evidence from 12 randomized controlled trials. Ann Palliat Med. 10(7):8215–8231.
   PubMed Web of Science ®Google Scholar
• Matsubara D, Takahagi S, Saito R, Kamegashira A, Tanaka A, Hide M. 2021. Analysis of the long-term economic burden of omalizumab on patients with chronic spontaneous urticaria. J Dermatol. 48(1):56–63.
   PubMed Web of Science ®Google Scholar
• Moy AP, Murali M, Nazarian RM. 2016. Identification of a Th2- and Th17-skewed immune phenotype in chronic urticaria with Th22 reduction dependent on autoimmunity and thyroid disease markers. J Cutan Pathol. 43(4):372–378.
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Br Med J. 372:n71.
   PubMed Web of Science ®Google Scholar
• Pei Y. 2017. Clinical observation of combination therapy for the treatment of chronic spontaneous urticaria. J Dermatol Venereol. 39:383–384. Chinese.
   Google Scholar
• Pereyra-Rodriguez JJ, Galán Gutiérrez M, Armario-Hita JC, Ruiz-Villaverde R. 2020. Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain. Dermatol Ther. 33(6):e13866.
   PubMed Web of Science ®Google Scholar
• Pi XB, Wang XX, Mai YM, Li JH. 2006. Effect of Tripterygium glycosides tablet combined with mizolastine for 22 cases with chronic spontaneous urticaria. South China J Dermato-Venereol. 13:130–132. Chinese.
   Google Scholar
• Qian M, Zhang SY. 2011. Clinical efficacy and life quality of Tripterygium glycosides combined with antihistamine for chronic urticaria. Chin J Dermatovenerol Integr Trad Western Med. 10:359–362. Chinese.
   Google Scholar
• Qin ZM, Han XM. 2017. Analysis of the efficacy of ebastine combined with Tripterygium glycosides for the treatment of chronic urticaria. J Clin Med. 4:17396–17396. Chinese.
   Google Scholar
• Ren Y, Zhang JL, Yang ZY. 2022. Effect of Biqi capsule combined with Tripterygium glycoside in the treatment of ankylosing spondylitis and its influence on blood hypercoagulable state and B and T lymphocyte attenuator. Clin Res Pract. 7:87–89. Chinese.
   Google Scholar
• Ru Y, Luo Y, Zhou Y, Kuai L, Sun X, Xing M, Liu L, Lu Y, Hong S, Chen X, et al. 2019. Adverse events associated with treatment of Tripterygium wilfordii Hook F: a quantitative evidence synthesis. Front Pharmacol. 10:1250.
   PubMed Web of Science ®Google Scholar
• Shi YS, Wang QM, Qiu XJ, Pang GX. 2019. Meta-analysis of efficacy and safety of Tripterygium glycosides tablets combined with desloratadine in treatment of chronic urticarial. Zhongguo Zhong Yao Za Zhi. 44(16):3551–3557. Chinese
   PubMedGoogle Scholar
• Takahagi S, Mihara S, Iwamoto K, Morioke S, Okabe T, Kameyoshi Y, Hide M. 2010. Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria. Allergy. 65(5):649–656.
   PubMed Web of Science ®Google Scholar
• Wang D. 2010. Observation of effect of ebastine combined with Tripterygium glycosides for the treatment of chronic urticaria. Med Inf. 23:4215–4217. Chinese.
   Google Scholar
• Wang Q. 2014. Observation of the efficacy of Tripterygium glycosides tablet combined with desloratadine for chronic spontaneous urticaria. Chin J Mod Drug Appl. 8(24):98–99. Chinese.
   Google Scholar
• Wang Y. 2018. Clinical observation of ebastine combined with Tripterygium glycosides for the treatment of chronic urticaria. Home Med. (12):176–177. Chinese.
   Google Scholar
• Wei YH, Zhang JH, An RZ, Wang JL. 2010. Combination effect of Tripterygium wilfordii with desloratadine on the treatment of chronic idiopathic urticaria. Chin J Derm Venereol. 24:1170–1172. Chinese.
   Google Scholar
• Xiao CC, Zhang CY. 2019. Clinical observation of setastine combined with Tripterygium glycosides tablet for the treatment of chronic urticaria. Chin J New Drugs. 28:2857–2859. Chinese.
   Google Scholar
• Xie YL, Mu SY, Zhao XF, Mu SL. 2012. Clinical effect of Tripterygium glycosides tablet combined with desloratadine for chronic spontaneous urticaria. China Rural Health. (z1):80–81. Chinese.
   Google Scholar
• Xing BF, Feng LX. 2017. Clinical study of desloratadine and Tripterygium wilfordii tablets in the treatment of chronic idiopathic urticaria. Chin Community Doct. 33(15):70,72. Chinese.
   Google Scholar
• Xu SX. 2018. Evaluation of the effect of ebastine combined with Tripterygium glycosides for chronic urticaria. For All Health. 12(2):161–162. Chinese.
   Google Scholar
• Yang HJ. 2019. Clinical efficacy of Tripterygium glycoside combined with desloratadine for chronic urticaria. J Med Aesthet Cosmetol. 28(2):77–77. Chinese.
   Google Scholar
• Yang L. 2011. Clinical observation of Tripterygium glycosides tablet combined with desloratadine for the treatment of chronic spontaneous urticaria. J China Trad Chin Med Inf. 3(17):130–130. Chinese.
   Google Scholar
• Yang ZM, Cheng JF, Chen MD, Liang YB. 2015. Effect of triptolide on IL-23/Th17(IL-17) inflammatory axis in asthmatic BALB/c mice. Chin J Immunol. 31:1347–1351,1356. Chinese
   Google Scholar
• Yao CY, Wang T, Jiang YL, Zheng X, Lin PH. 2017. Effect of celastrol on mast cell and PI3K/AKT/GSK3-ß pathway. Fujian Med J. 39(1):61–64. Chinese.
   Google Scholar
• Zhang BY. 2021. Efficacy of Tripterygium glycosides combined with secondary H1-antihistamine for the treatment of chronic urticaria. Contemp Med Symp. 19(10):145–146. Chinese.
   Google Scholar
• Zhang XJ, Ma Y. 2021. Efficacy and safety of ebastine combined with Tripterygium glycosides tablet for chronic urticaria. J North Pharm. 18(5):119–120. Chinese.
   Google Scholar
• Zhang X, Song X, Zhang M, Li C, Huang Z, Liu B, Yu M, Liao S, Luan T, Zuberbier T, et al. 2022. Prevalence and risk factors of chronic urticaria in China: a nationwide cross-sectional study. Allergy. 77(7):2233–2236.
   PubMed Web of Science ®Google Scholar
• Zhang WY, Wang T, Xu NH, Chen JY. 2018. Celastrol down-regulate the NK-1R mRNA expression of mast cell mediated by substance P. Fujian Med J. 40(1):120–123. Chinese.
   Google Scholar
• Zhao RY. 2018. Efficacy of Tripterygium glycosides tablet combined with desloratadine for the treatment of chronic spontaneous urticaria. Health Must-Read Mag. (18):109–109. Chinese.
   Google Scholar
• Zhong JX, Yan HF, Huo KM, Gu YN, Huang XX, Zhuang XJ, Chen HB. 2020. The effect of gamma globulin combined with Tripterygium wilfordii glycoside on children with Henoch-Schonlein purpura nephritis. Chin J Diffic Complicat Cases. 19:66–70. Chinese.
   Google Scholar
• Zhou ZD. 2014. Analysis of the efficacy of Tripterygium glycosides tablet combined with desloratadine for the treatment of chronic spontaneous urticaria. Med Inf. 27(11):304–305. Chinese.
   Google Scholar
• Zhou ML, Lu MH, Liu JP, Liu LL, Yin BH, Gao SQ. 2018. Effect of Tripterygium glycosides tablet on the serum levels of endostatin and TSP-1 in patients with chronic spontaneous urticaria. Lab Med Clinic. 15:973–975. Chinese.
   Google Scholar
• Zhu XL. 2018. Effect of desloratadine combined with Tripterygium glycosides tablet in the treatment of chronic spontaneous urticaria. Home Med. (9):58–59. Chinese.
   Google Scholar
• Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, Ballmer-Weber B, Bangert C, Ben-Shoshan M, Bernstein JA, et al. 2022. The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 77(3):734–766.
   PubMed Web of Science ®Google Scholar